title: [Chest X-ray features of severe acute respiratory syndrome and clinical staging].
abstract: OBJECTIVE
  To establish a clinical staging system for patients with severe acute respiratory syndrome (SARS) based on clinical feature, laboratory tests as well as dynamic changes of chest X-ray images.
  
  
  METHODS
  Dynamic changes of chest X-ray images and laboratory tests in 45 SARS patients managed from March to May, 2003 were analyzed.
  
  
  RESULTS
  (1) Chest X-ray image: among 45 cases, 23 were common type: the time to appearance of unilateral patched shadow of the lung were 2 to 5 (2.9 +/- 1.0) days. The time to appearance of bilateral patched shadow of the lungs were 2 to 12 (6.9 +/- 2.5) days. The time to appearance of ground glass or consolidation in the lung were 6 to 19 (11.0 +/- 2.0) days. The time to the beginning of absorption of X-ray changes were 10 to 21 (15.0 +/- 4.1) days. The time for chest X-ray image to be absorbed completely were 18 to 46 (25.9 +/- 7.2) days. Twenty-two patients were severe type, in which the time to the appearance of ground glass of the lung were (9.0 +/- 3.2) days, with no significant difference when compared with common type (P < 0.05). However, the time to the beginning of absorption and complete absorption were (19.0 +/- 4.6) days (P = 0.009) and (36.0 +/- 8.1) days (P = 0.001), respectively. Noticeably, the time to pan-consolidation of the lung were less than 7 days in 7 fatal cases. (2) Laboratory tests: decrease in the number of lymphocytes and T lymphocyte subset were seen in the early stage. While the account recovered in 10 to 14 days of disease course in the 38 patients who survived, there was no recovery in 7 patients who died.
  
  
  CONCLUSIONS
  SARS can be divided into five stages: incubation period 2 to 10 days, prodromal period 1 to 3 days, progressive period 4 to 7 days, advanced period 8 to 15 days were, convalescent period 16 to 24 days. The appearance of pan-consolidation in the lung in less than 7 days and/or unable to recover the number of lymphocytes and T lymphocyte subset will be associated with poor prognosis.
authors.affiliation: Department of Infectious Diseases, Beijing Youan Hospital, Capital University of Medical Science, Beijing 100054, China. xinxin0797@sina.com.cn
authors.forename: Xin-hui
authors.initials: XH
authors.lastname: Guo
authors.forename: Ke
authors.initials: K
authors.lastname: Zhang
authors.forename: Da-wei
authors.initials: DW
authors.lastname: Zhao
authors.forename: Tian-ge
authors.initials: TG
authors.lastname: Zhang
authors.forename: Yan-bin
authors.initials: YB
authors.lastname: Guo
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013902:Radiography, Thoracic; D045169:Severe Acute Respiratory Syndrome / Q000145:classification / Q000000981:diagnostic imaging* / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology